Iproteos: Science at the service of patients

Teresa Tarragó is co-founder of IProteos, an IRB Barcelona spinf-off (D. Portales)

Teresa Tarragó is co-founder of IProteos, an IRB Barcelona spinf-off (D. Portales)


Innovaspain.com has dedicated an article to the research undertaken by Iproteos, a company specialized in the discovery of drugs for diseases of the nervous system. This spin-off company of IRB Barcelona has demonstrated the effectiveness of a novel compound, IPR-19, to reverse the cognitive deficit associated with schizophrenia in mouse models. At present, this peptide is in the preclinical phase.

Link to Innovaspain.com